title: Hypertension in pregnancy.
abstract: Hypertension is a common complication of pregnancy. Preeclampsia, in particular, is associated with substantial risk to both the mother and the fetus. Several risk factors have been recognized to predict risk for preeclampsia. However, at present no biomarkers have sufficient discriminatory ability to be useful in clinical practice, and no effective preventive strategies have yet been identified. Commonly used medications for the treatment of hypertension in pregnancy include methyldopa and labetalol. Blood pressure thresholds for initiating antihypertensive therapy are higher than outside of pregnancy. Women with prior preeclampsia are at increased risk of hypertension, cardiovascular disease, and renal disease.
authors: Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA. cgsolomon@bics.bwh.harvard.edu
authors: Caren G
authors: CG
authors: Solomon
authors: Ellen W
authors: EW
authors: Seely
mesh_terms: D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005317:Fetal Growth Retardation / Q000209:etiology; D005333:Fetus / Q000503:physiopathology; D005865:Gestational Age; D006801:Humans; D006973:Hypertension; D046110:Hypertension, Pregnancy-Induced; D007231:Infant, Newborn; D007236:Infant, Small for Gestational Age; D011225:Pre-Eclampsia / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular; D011256:Pregnancy Outcome; D047928:Premature Birth; D012307:Risk Factors
chemical_list: D000959:Antihypertensive Agents